Iovance Biotherapeutics: High-Risk Cancer Stock Potential
A bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
Explore the main factors that move a stock index, including macroeconomic data, earnings, and policy changes that influence index levels.
21,956 articlesA bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
Planet Labs delivered its first full year of profitability, with a ballooning backlog and AI partnerships driving a r...
Exxon's decision to redomicile to Texas sets off a broader dialog on governance. The texas stock exchange ceo argues ...
Target shares surged to a fresh all-time high after a robust Q1 report, sparking questions about how long the rally c...
Liberty Formula One stock trades around $83 after a strong Q4. Jim Cramer flags the pullback as a terrific buying opp...
Disney reports stronger-than-expected Q2 2026 results, lifting the stock 8% in early trading as streaming and parks r...
Two Harbors Investment Corp. delayed its stockholder meeting again as votes on the CrossCountry Mortgage affiliate sa...
RH has endured a steep decline over five years. This article breaks down whether the luxury home brand can stage a re...
TransMedics has surged 104% over the last year, catching investors’ eyes. This guide breaks down the business, the ca...
GameStop is weighing a bold move: acquiring eBay. This article breaks down whether does Gamestop's proposed acquisiti...
Natera shows growth through AI-enabled cell-free DNA tests and a widening data moat, positioning it as a leading nate...
Webull's growth is accelerating, but profitability remains elusive. This piece analyzes the prediction: webull stock ...